Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Constant Contact Inc (CTCT): Insiders Aren’t Crazy About It But Hedge Funds Love It

Page 1 of 2

In today’s marketplace, there are many gauges shareholders can use to track their holdings. A duo of the most under-the-radar are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the top fund managers can outperform the broader indices by a superb margin (see just how much).

Constant Contact Inc (NASDAQ:CTCT)

Equally as useful, optimistic insider trading activity is another way to look at the financial markets. Obviously, there are many stimuli for an executive to cut shares of his or her company, but just one, very simple reason why they would behave bullishly. Several academic studies have demonstrated the impressive potential of this strategy if shareholders understand where to look (learn more here).

What’s more, let’s study the latest info for Constant Contact Inc (NASDAQ:CTCT).

Hedge fund activity in Constant Contact Inc (NASDAQ:CTCT)

Heading into Q3, a total of 10 of the hedge funds we track held long positions in this stock, a change of 25% from the first quarter. With hedge funds’ positions undergoing their usual ebb and flow, there exists an “upper tier” of noteworthy hedge fund managers who were upping their stakes significantly.

When using filings from the hedgies we track, Soros Fund Management, managed by George Soros, holds the most valuable position in Constant Contact Inc (NASDAQ:CTCT). Soros Fund Management has a $12.1 million position in the stock, comprising 0.1% of its 13F portfolio. On Soros Fund Management’s heels is Jim Simons of Renaissance Technologies, with a $2.6 million position; the fund has less than 0.1%% of its 13F portfolio invested in the stock. Some other peers that are bullish include Israel Englander’s Millennium Management, D. E. Shaw’s D E Shaw and Glenn Russell Dubin’s Highbridge Capital Management.

Consequently, specific money managers were leading the bulls’ herd. Soros Fund Management, managed by George Soros, created the largest position in Constant Contact Inc (NASDAQ:CTCT). Soros Fund Management had 12.1 million invested in the company at the end of the quarter. Jim Simons’s Renaissance Technologies also made a $2.6 million investment in the stock during the quarter. The following funds were also among the new CTCT investors: Israel Englander’s Millennium Management, D. E. Shaw’s D E Shaw, and Glenn Russell Dubin’s Highbridge Capital Management.

What have insiders been doing with Constant Contact Inc (NASDAQ:CTCT)?

Insider buying made by high-level executives is most useful when the company in focus has experienced transactions within the past six months. Over the latest six-month time frame, Constant Contact Inc (NASDAQ:CTCT) has experienced zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll also review the relationship between both of these indicators in other stocks similar to Constant Contact Inc (NASDAQ:CTCT). These stocks are Marchex, Inc. (NASDAQ:MCHX), National CineMedia, Inc. (NASDAQ:NCMI), MDC Partners Inc. (USA) (NASDAQ:MDCA), Millennial Media, Inc. (NYSE:MM), and Harte-Hanks, Inc. (NYSE:HHS). This group of stocks are in the marketing services industry and their market caps are closest to CTCT’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!